John Nakayama, MD, discusses the significance of the NRG GY018 study in endometrial cancer.
John Nakayama, MD
Advertisement
Articles by John Nakayama, MD
John Nakayama, MD, discusses what the evolution of endometrial cancer treatment has looked like in recent years.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
